Half-year report · HY
9989.TEDINET S100X3XF
Period2025-04-01 → 2025-09-30
Filed2025-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥418.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥801.8bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥395.6bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥23.1bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥21.2bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥22.9bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥43.8bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.8bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥22.7bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥20.5bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥15.3bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥30.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥14.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥15.3bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥14.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥450.6bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥444.0bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥420.0bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥173.2bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥174.3bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥277.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥269.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥260.8bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥66.1bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥65.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥66.1bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥65.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥63.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥69.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥21.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥41.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥19.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥17.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥35.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥18.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥10.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥130.54 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥262.91 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥122.02 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 61.6% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.7% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.1% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥30.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥30.4bn |
| Discount Storereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥181.8bn |
| Discount Storereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥181.8bn |
| Discount Storereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥6m |
| Discount Storereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥9.8bn |
| Drug Storereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥267.0bn |
| Drug Storereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥236.6bn |
| Drug Storereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥30.4bn |
| Drug Storereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥13.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥448.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥418.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥30.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥23.1bn |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥28.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥28.5bn |
| Discount Storereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥168.4bn |
| Discount Storereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥168.4bn |
| Discount Storereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6m |
| Discount Storereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥8.6bn |
| Drug Storereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥255.6bn |
| Drug Storereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥227.2bn |
| Drug Storereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥28.5bn |
| Drug Storereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥12.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥424.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥395.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥28.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥21.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 499
| Item | Context | Value | Unit |
|---|---|---|---|
| Interest and dividends income received ope cf inv cf | Prior1InterimDuration | 11000000 | JPY |
| Interest and dividends income received ope cf inv cf | InterimDuration | 57000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1InterimDuration | -58000000 | JPY |
| Interest expenses paid ope cf fin cf | InterimDuration | -153000000 | JPY |
| Income taxes paid ope cf | Prior1InterimDuration | -6039000000 | JPY |
| Income taxes paid ope cf | InterimDuration | -6589000000 | JPY |
| Proceeds from subsidy ope cf | Prior1InterimDuration | 134000000 | JPY |
| Proceeds from subsidy ope cf | InterimDuration | 43000000 | JPY |
| Net cash provided by used in operating activities | Prior1InterimDuration | 19187000000 | JPY |
| Net cash provided by used in operating activities | InterimDuration | 21242000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1InterimDuration | -17335000000 | JPY |
| Purchase of property plant and equipment inv cf | InterimDuration | -16335000000 | JPY |
| Purchase of intangible assets inv cf | Prior1InterimDuration | -432000000 | JPY |
| Purchase of intangible assets inv cf | InterimDuration | -573000000 | JPY |
| Payments of loans receivable inv cf | Prior1InterimDuration | -328000000 | JPY |
| Payments of loans receivable inv cf | InterimDuration | -141000000 | JPY |
| Payments for lease and guarantee deposits inv cf | Prior1InterimDuration | -407000000 | JPY |
| Payments for lease and guarantee deposits inv cf | InterimDuration | -386000000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | Prior1InterimDuration | 341000000 | JPY |
| Proceeds from collection of lease and guarantee deposits inv cf | InterimDuration | 307000000 | JPY |
| Other net inv cf | Prior1InterimDuration | -147000000 | JPY |
| Other net inv cf | InterimDuration | -281000000 | JPY |
| Net cash provided by used in investment activities | Prior1InterimDuration | -18309000000 | JPY |
| Net cash provided by used in investment activities | InterimDuration | -17410000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1InterimDuration | -35000000000 | JPY |
| Net increase decrease in short term loans payable fin cf | InterimDuration | 1000000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1InterimDuration | 35000000000 | JPY |
| Proceeds from long term loans payable fin cf | InterimDuration | 6000000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -583000000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -2050000000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -6664000000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -7601000000 | JPY |
| Purchase of treasury stock fin cf | Prior1InterimDuration | -0 | JPY |
| Purchase of treasury stock fin cf | InterimDuration | -0 | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | -7248000000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -2651000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | -6370000000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | 1180000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 69698000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 64956000000 | JPY |
| Increase in cash and cash equivalents resulting from merger with unconsolidated subsidiaries cce | Prior1InterimDuration | 65000000 | JPY |
| Increase in cash and cash equivalents resulting from merger with unconsolidated subsidiaries cce | InterimDuration | － | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 63394000000 | JPY |
| Cash and cash equivalents | InterimInstant | 66137000000 | JPY |
| Salaries allowances and bonuses sga | Prior1InterimDuration | 28733000000 | JPY |
| Salaries allowances and bonuses sga | InterimDuration | 31138000000 | JPY |
| Rent expenses sga | Prior1InterimDuration | 16488000000 | JPY |
| Rent expenses sga | InterimDuration | 17332000000 | JPY |
| Provision for directors bonuses sga | Prior1InterimDuration | 80000000 | JPY |
| Provision for directors bonuses sga | InterimDuration | 81000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |